+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Podoplanin and VEGF-C immunoexpression in oral squamous cell carcinomas: prognostic significance



Podoplanin and VEGF-C immunoexpression in oral squamous cell carcinomas: prognostic significance



Anticancer Research 33(9): 3969-3976



This study evaluated the clinical significance of podoplanin and vascular endothelial growth factor-C (VEGF-C) expression in oral squamous cell carcinoma (OSCC). The immunohistochemical expression of podoplanin and VEGF-C were investigated in 42 well-differentiated OSCCs. The Chi-square test was used to analyze the association of biomarker expression with the clinical characteristics, treatment, and outcome, as well as with histopathological microscopic features and histopathological malignancy index. The relationship between podoplanin, VEGF-C and prognosis was also studied. Survival rates were calculated by the Kaplan Meier method. Strong podoplanin expression was associated with male gender (p=0.037) and with early clinical stage (I-II) (p=0.027). Strong podoplanin expression was more frequently found in patients with perineural infiltration. Podoplanin and VEGF-C expression were not significant prognostic factors for patients with OSCC. These results suggest that the strong podoplanin and VEGF-C expression by malignant cells is associated with perineural invasion in patients with OSCC.

(PDF emailed within 1 workday: $29.90)

Accession: 055032935

Download citation: RISBibTeXText

PMID: 24023336


Related references

Prognostic significance of CD44v6, p63, podoplanin and MMP-9 in oral squamous cell carcinomas. Oral Diseases 22(4): 303-312, 2017

Prognostic significance of VEGF-C, semaphorin 3F, and neuropilin-2 expression in oral squamous cell carcinomas and their relationship with lymphangiogenesis. Journal of Surgical Oncology 111(4): 382-388, 2015

Biological significance and regulation of podoplanin expression in oral squamous cell carcinomas. Journal of Oral and Maxillofacial Surgery 72(9): E182-E183, 2014

Immunoexpression and prognostic significance of TIMP-1 and -2 in oral squamous cell carcinoma. Oral Oncology 41(6): 568-579, 2005

Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy. Oncology Letters 6(6): 1611-1615, 2013

Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas. Pathobiology 78(3): 171-180, 2011

VEGF, CD105 and α-SMA immunoexpression study in lips squamous cell carcinomas and associated dysplastic lesions. Romanian Journal of Morphology and Embryology 55(1): 35-41, 2015

Expression of VEGF, EGFR, p16 in lip cancers and oral squamous cell carcinomas and their clinic significance. Zhonghua Kou Qiang Yi Xue Za Zhi 37(2): 99-101, 2002

Prognostic significance of histopathological parameters in oral squamous cell carcinomas. Laboratory Investigation 81(1): 151A, 2001

Lack of prognostic significance for p53-overexpression and Ki-67-immunoreactivity in oral T1-2 squamous cell carcinomas. Oncology Reports 4(4): 737-742, 1997

Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas. Oral Oncology 39(6): 610-618, 2003

Oral squamous cell carcinomas in age distinct population: a comparison of p53 immunoexpression. Journal of Cancer Research and Therapeutics 9(4): 587-591, 2014

Prognostic significance of VEGF-C in predicting micrometastasis and isolated tumour cells in N0 oral squamous cell carcinoma. Journal of Oral Pathology and Medicine 46(3): 194-200, 2016

Prognostic significance of macrophage polarization in early stage oral squamous cell carcinomas. Oral Oncology 52: 75-84, 2016

Prognostic significance of p21WAF1/CIP1 expression in oral tongue squamous cell carcinomas. International Journal of Cancer Supplement (13): 259, 2002